BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND MLH1, COCA2, 4292, ENSG00000076242, hMLH1, FCC2, HNPCC2, P40692, MGC5172, HNPCC AND Treatment
14 results:

  • 1. Constitutional Mismatch Repair Deficiency Syndrome as a Cause of Numerous Malignancies in a Teenage Patient-A Case Report.
    Samborska M; Galli D; Achkar R; Thambyrajah S; Derwich K
    J Pediatr Hematol Oncol; 2023 Oct; 45(7):e917-e920. PubMed ID: 37526375
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Lynch syndrome-associated chordoma with high tumor mutational burden and significant response to immune checkpoint inhibitors.
    Shinojima N; Ozono K; Yamamoto H; Abe S; Sasaki R; Tomita Y; Kai A; Mori R; Yamamoto T; Uekawa K; Matsui H; Nosaka K; Matsuzaki H; Komohara Y; Mikami Y; Mukasa A
    Brain Tumor Pathol; 2023 Jul; 40(3):185-190. PubMed ID: 37086325
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Expression of Programmed Cell Death-L1 (PD-L1) Protein and Mismatch Repair Mutations in Orbital Tumours-a Pilot Study.
    AlSemari MA; Strianese D; Abu Safieh L; Al Hussain H; Abedalthagafi M; Edward DP
    Eur J Ophthalmol; 2022 Sep; 32(5):3097-3102. PubMed ID: 34931541
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Bilateral pleural effusion associated with atezolizumab in a patient with Lynch syndrome-related urothelial carcinoma: a case report.
    Yhim HY; Jeon SY; Lee CH; Lee NR
    Ann Palliat Med; 2022 Jun; 11(6):2162-2169. PubMed ID: 34328007
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Long-term complete remission with Ipilimumab in metastatic castrate-resistant prostate cancer: case report of two patients.
    Cabel L; Loir E; Gravis G; Lavaud P; Massard C; Albiges L; Baciarello G; Loriot Y; Fizazi K
    J Immunother Cancer; 2017; 5():31. PubMed ID: 28428880
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Molecular Heterogeneity of Ewing Sarcoma as Detected by Ion Torrent Sequencing.
    Zhang N; Liu H; Yue G; Zhang Y; You J; Wang H
    PLoS One; 2016; 11(4):e0153546. PubMed ID: 27077911
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Genetic diagnosis of high-penetrance susceptibility for colorectal cancer (CRC) is achievable for a high proportion of familial CRC by exome sequencing.
    Chubb D; Broderick P; Frampton M; Kinnersley B; Sherborne A; Penegar S; Lloyd A; Ma YP; Dobbins SE; Houlston RS
    J Clin Oncol; 2015 Feb; 33(5):426-32. PubMed ID: 25559809
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Functional and physical interaction between the mismatch repair and FA-BRCA pathways.
    Williams SA; Wilson JB; Clark AP; Mitson-Salazar A; Tomashevski A; Ananth S; Glazer PM; Semmes OJ; Bale AE; Jones NJ; Kupfer GM
    Hum Mol Genet; 2011 Nov; 20(22):4395-410. PubMed ID: 21865299
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Ameloblastoma of the jaws: a retrospective analysis of 340 cases in a Malaysian population.
    Siar CH; Lau SH; Ng KH
    J Oral Maxillofac Surg; 2012 Mar; 70(3):608-15. PubMed ID: 21723654
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. High-dose estrogen as salvage hormonal therapy for highly refractory metastatic breast cancer: a retrospective chart review.
    Mahtani RL; Stein A; Vogel CL
    Clin Ther; 2009; 31 Pt 2():2371-8. PubMed ID: 20110046
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Differential radiosensitization in DNA mismatch repair-proficient and -deficient human colon cancer xenografts with 5-iodo-2-pyrimidinone-2'-deoxyribose.
    Seo Y; Yan T; Schupp JE; Colussi V; Taylor KL; Kinsella TJ
    Clin Cancer Res; 2004 Nov; 10(22):7520-8. PubMed ID: 15569982
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Aberrant promoter CpG methylation as a molecular marker for disease monitoring in natural killer cell lymphomas.
    Siu LL; Chan JK; Wong KF; Choy C; Kwong YL
    Br J Haematol; 2003 Jul; 122(1):70-7. PubMed ID: 12823347
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Drug treatment in the development of mismatch repair defective acute leukemia and myelodysplastic syndrome.
    Casorelli I; Offman J; Mele L; Pagano L; Sica S; D'Errico M; Giannini G; Leone G; Bignami M; Karran P
    DNA Repair (Amst); 2003 May; 2(5):547-59. PubMed ID: 12713812
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Base excision repair as a therapeutic target in colon cancer.
    Liu L; Nakatsuru Y; Gerson SL
    Clin Cancer Res; 2002 Sep; 8(9):2985-91. PubMed ID: 12231545
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.